NCT03506477View on ClinicalTrials.gov

Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 21, 2018

Primary Completion Date

September 25, 2019

Study Completion Date

September 25, 2019

Conditions
Plaque PsoriasisPsoriasis
Interventions
DRUG

Enstilar® foam

for 4 weeks

DRUG

Vehicle foam

for 4 weeks

Trial Locations (1)

10023

Mount Sinai West, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT03506477 - Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color | Biotech Hunter | Biotech Hunter